Gene symbol: Camk2a

Also known as: PKCCD; PK2CDD

Organism: Rattus norvegicus

Summary: Enables GTPase activating protein binding activity and calmodulin-dependent protein kinase activity. Involved in several processes, including NMDA selective glutamate receptor signaling pathway; protein phosphorylation; and regulation of protein localization to cell periphery. Located in several cellular components, including dendrite cytoplasm; glutamatergic postsynaptic density; and neuronal cell body. Is active in several cellular components, including glutamatergic synapse; postsynaptic cytosol; and presynaptic cytosol. Biomarker of middle cerebral artery infarction and transient cerebral ischemia. Human ortholog(s) of this gene implicated in autosomal dominant mental retardation 53 and autosomal recessive non-syndromic intellectual disability. Orthologous to human CAMK2A (calcium/calmodulin dependent protein kinase II alpha). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 25400 Ensembl:ENSRNOG00000018712 AllianceGenome:RGD:2261


GO Annotation


Category Term ID Term description
Process GO:0000082 G1/S transition of mitotic cell cycle
Process GO:0000278 Mitotic cell cycle
Process GO:0000902 Cell morphogenesis
Process GO:0000904 Cell morphogenesis involved in differentiation
Process GO:0001505 Regulation of neurotransmitter levels
Process GO:0002931 Response to ischemia
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006468 Protein phosphorylation
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006812 Cation transport
Process GO:0006816 Calcium ion transport
Process GO:0006839 Mitochondrial transport
Process GO:0006915 Apoptotic process
Process GO:0006950 Response to stress
Process GO:0006996 Organelle organization
Process GO:0007005 Mitochondrion organization
Process GO:0007006 Mitochondrial membrane organization
Process GO:0007049 Cell cycle
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007186 G protein-coupled receptor signaling pathway
Process GO:0007215 Glutamate receptor signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0008152 Metabolic process
Process GO:0008219 Cell death
Process GO:0008277 Regulation of G protein-coupled receptor signaling pathway
Process GO:0008637 Apoptotic mitochondrial changes
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010646 Regulation of cell communication
Process GO:0010660 Regulation of muscle cell apoptotic process
Process GO:0010661 Positive regulation of muscle cell apoptotic process
Process GO:0010662 Regulation of striated muscle cell apoptotic process
Process GO:0010663 Positive regulation of striated muscle cell apoptotic process
Process GO:0010665 Regulation of cardiac muscle cell apoptotic process
Process GO:0010666 Positive regulation of cardiac muscle cell apoptotic process
Process GO:0010941 Regulation of cell death
Process GO:0010942 Positive regulation of cell death
Process GO:0010959 Regulation of metal ion transport
Process GO:0012501 Programmed cell death
Process GO:0016043 Cellular component organization
Process GO:0016310 Phosphorylation
Process GO:0016358 Dendrite development
Process GO:0018105 Peptidyl-serine phosphorylation
Process GO:0018107 Peptidyl-threonine phosphorylation
Process GO:0018193 Peptidyl-amino acid modification
Process GO:0018209 Peptidyl-serine modification
Process GO:0018210 Peptidyl-threonine modification
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0022008 Neurogenesis
Process GO:0022402 Cell cycle process
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0030001 Metal ion transport
Process GO:0030030 Cell projection organization
Process GO:0030154 Cell differentiation
Process GO:0030182 Neuron differentiation
Process GO:0030334 Regulation of cell migration
Process GO:0031175 Neuron projection development
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031503 Protein-containing complex localization
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032870 Cellular response to hormone stimulus
Process GO:0032879 Regulation of localization
Process GO:0032880 Regulation of protein localization
Process GO:0032989 Cellular component morphogenesis
Process GO:0032990 Cell part morphogenesis
Process GO:0035235 Ionotropic glutamate receptor signaling pathway
Process GO:0036211 Protein modification process
Process GO:0038166 Angiotensin-activated signaling pathway
Process GO:0040012 Regulation of locomotion
Process GO:0042221 Response to chemical
Process GO:0042981 Regulation of apoptotic process
Process GO:0043065 Positive regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043068 Positive regulation of programmed cell death
Process GO:0043086 Negative regulation of catalytic activity
Process GO:0043170 Macromolecule metabolic process
Process GO:0043269 Regulation of ion transport
Process GO:0043270 Positive regulation of ion transport
Process GO:0043412 Macromolecule modification
Process GO:0043434 Response to peptide hormone
Process GO:0044092 Negative regulation of molecular function
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044770 Cell cycle phase transition
Process GO:0044772 Mitotic cell cycle phase transition
Process GO:0044843 Cell cycle G1/S phase transition
Process GO:0046777 Protein autophosphorylation
Process GO:0046902 Regulation of mitochondrial membrane permeability
Process GO:0046907 Intracellular transport
Process GO:0046928 Regulation of neurotransmitter secretion
Process GO:0048167 Regulation of synaptic plasticity
Process GO:0048168 Regulation of neuronal synaptic plasticity
Process GO:0048468 Cell development
Process GO:0048518 Positive regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048666 Neuron development
Process GO:0048667 Cell morphogenesis involved in neuron differentiation
Process GO:0048699 Generation of neurons
Process GO:0048731 System development
Process GO:0048812 Neuron projection morphogenesis
Process GO:0048813 Dendrite morphogenesis
Process GO:0048856 Anatomical structure development
Process GO:0048858 Cell projection morphogenesis
Process GO:0048869 Cellular developmental process
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050794 Regulation of cellular process
Process GO:0050804 Modulation of chemical synaptic transmission
Process GO:0050896 Response to stimulus
Process GO:0051046 Regulation of secretion
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051091 Positive regulation of DNA-binding transcription factor activity
Process GO:0051092 Positive regulation of NF-kappaB transcription factor activity
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051346 Negative regulation of hydrolase activity
Process GO:0051588 Regulation of neurotransmitter transport
Process GO:0051641 Cellular localization
Process GO:0051649 Establishment of localization in cell
Process GO:0051668 Localization within membrane
Process GO:0051716 Cellular response to stimulus
Process GO:0051924 Regulation of calcium ion transport
Process GO:0051928 Positive regulation of calcium ion transport
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060341 Regulation of cellular localization
Process GO:0060996 Dendritic spine development
Process GO:0061024 Membrane organization
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071310 Cellular response to organic substance
Process GO:0071375 Cellular response to peptide hormone stimulus
Process GO:0071417 Cellular response to organonitrogen compound
Process GO:0071495 Cellular response to endogenous stimulus
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0080090 Regulation of primary metabolic process
Process GO:0090559 Regulation of membrane permeability
Process GO:0097120 Receptor localization to synapse
Process GO:0098696 Regulation of neurotransmitter receptor localization to postsynaptic specialization membrane
Process GO:0098953 Receptor diffusion trapping
Process GO:0098970 Postsynaptic neurotransmitter receptor diffusion trapping
Process GO:0098989 NMDA selective glutamate receptor signaling pathway
Process GO:0099004 Calmodulin dependent kinase signaling pathway
Process GO:0099072 Regulation of postsynaptic membrane neurotransmitter receptor levels
Process GO:0099148 Regulation of synaptic vesicle docking
Process GO:0099177 Regulation of trans-synaptic signaling
Process GO:0099628 Neurotransmitter receptor diffusion trapping
Process GO:0106020 Regulation of vesicle docking
Process GO:0120036 Plasma membrane bounded cell projection organization
Process GO:0120039 Plasma membrane bounded cell projection morphogenesis
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901652 Response to peptide
Process GO:1901653 Cellular response to peptide
Process GO:1901698 Response to nitrogen compound
Process GO:1901699 Cellular response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902108 Regulation of mitochondrial membrane permeability involved in apoptotic process
Process GO:1902473 Regulation of protein localization to synapse
Process GO:1902683 Regulation of receptor localization to synapse
Process GO:1903047 Mitotic cell cycle process
Process GO:1903076 Regulation of protein localization to plasma membrane
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903530 Regulation of secretion by cell
Process GO:1904375 Regulation of protein localization to cell periphery
Process GO:1904385 Cellular response to angiotensin
Process GO:1905475 Regulation of protein localization to membrane
Process GO:1990443 Peptidyl-threonine autophosphorylation
Process GO:1990776 Response to angiotensin
Process GO:1990806 Ligand-gated ion channel signaling pathway
Process GO:2000124 Regulation of endocannabinoid signaling pathway
Process GO:2000145 Regulation of cell motility
Process GO:2001141 Regulation of RNA biosynthetic process
Process GO:2001222 Regulation of neuron migration
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005739 Mitochondrion
Component GO:0005829 Cytosol
Component GO:0005886 Plasma membrane
Component GO:0005954 Calcium- and calmodulin-dependent protein kinase complex
Component GO:0014069 Postsynaptic density
Component GO:0016020 Membrane
Component GO:0030054 Cell junction
Component GO:0030424 Axon
Component GO:0030425 Dendrite
Component GO:0032279 Asymmetric synapse
Component GO:0032838 Plasma membrane bounded cell projection cytoplasm
Component GO:0032839 Dendrite cytoplasm
Component GO:0032991 Protein-containing complex
Component GO:0036477 Somatodendritic compartment
Component GO:0042995 Cell projection
Component GO:0043005 Neuron projection
Component GO:0043025 Neuronal cell body
Component GO:0043197 Dendritic spine
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0044297 Cell body
Component GO:0044309 Neuron spine
Component GO:0045202 Synapse
Component GO:0045211 Postsynaptic membrane
Component GO:0070161 Anchoring junction
Component GO:0071944 Cell periphery
Component GO:0097060 Synaptic membrane
Component GO:0097447 Dendritic tree
Component GO:0098590 Plasma membrane region
Component GO:0098685 Schaffer collateral - CA1 synapse
Component GO:0098793 Presynapse
Component GO:0098794 Postsynapse
Component GO:0098978 Glutamatergic synapse
Component GO:0098984 Neuron to neuron synapse
Component GO:0099522 Cytosolic region
Component GO:0099523 Presynaptic cytosol
Component GO:0099524 Postsynaptic cytosol
Component GO:0099568 Cytoplasmic region
Component GO:0099572 Postsynaptic specialization
Component GO:0099573 Glutamatergic postsynaptic density
Component GO:0099634 Postsynaptic specialization membrane
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:0120111 Neuron projection cytoplasm
Component GO:0140535 Intracellular protein-containing complex
Function GO:0000166 Nucleotide binding
Function GO:0003824 Catalytic activity
Function GO:0004672 Protein kinase activity
Function GO:0004674 Protein serine/threonine kinase activity
Function GO:0004683 Calmodulin-dependent protein kinase activity
Function GO:0005102 Signaling receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005516 Calmodulin binding
Function GO:0005524 ATP binding
Function GO:0009931 Calcium-dependent protein serine/threonine kinase activity
Function GO:0010857 Calcium-dependent protein kinase activity
Function GO:0016301 Kinase activity
Function GO:0016740 Transferase activity
Function GO:0016772 Transferase activity, transferring phosphorus-containing groups
Function GO:0016773 Phosphotransferase activity, alcohol group as acceptor
Function GO:0017076 Purine nucleotide binding
Function GO:0030554 Adenyl nucleotide binding
Function GO:0032553 Ribonucleotide binding
Function GO:0032555 Purine ribonucleotide binding
Function GO:0032559 Adenyl ribonucleotide binding
Function GO:0032794 GTPase activating protein binding
Function GO:0035254 Glutamate receptor binding
Function GO:0035639 Purine ribonucleoside triphosphate binding
Function GO:0036094 Small molecule binding
Function GO:0042802 Identical protein binding
Function GO:0042803 Protein homodimerization activity
Function GO:0043167 Ion binding
Function GO:0043168 Anion binding
Function GO:0043169 Cation binding
Function GO:0046872 Metal ion binding
Function GO:0046983 Protein dimerization activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:0106310 Protein serine kinase activity
Function GO:0140096 Catalytic activity, acting on a protein
Function GO:1901265 Nucleoside phosphate binding
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-112314 Neurotransmitter receptors and postsynaptic signal transmission
RCTM RNO-112315 Transmission across Chemical Synapses
RCTM RNO-112316 Neuronal System
RCTM RNO-1280215 Cytokine Signaling in Immune system
RCTM RNO-162582 Signal Transduction
RCTM RNO-168256 Immune System
RCTM RNO-195721 Signaling by WNT
RCTM RNO-2262752 Cellular responses to stress
RCTM RNO-3371556 Cellular response to heat stress
RCTM RNO-3371571 HSF1-dependent transactivation
RCTM RNO-382551 Transport of small molecules
RCTM RNO-3858494 Beta-catenin independent WNT signaling
RCTM RNO-397014 Muscle contraction
RCTM RNO-399719 Trafficking of AMPA receptors
RCTM RNO-399721 Glutamate binding, activation of AMPA receptors and synaptic plasticity
RCTM RNO-4086398 Ca2+ pathway
RCTM RNO-438066 Unblocking of NMDA receptors, glutamate binding and activation
RCTM RNO-442755 Activation of NMDA receptors and postsynaptic events
RCTM RNO-5576891 Cardiac conduction
RCTM RNO-5578775 Ion homeostasis
RCTM RNO-5673000 RAF activation
RCTM RNO-5673001 RAF/MAP kinase cascade
RCTM RNO-5683057 MAPK family signaling cascades
RCTM RNO-5684996 MAPK1/MAPK3 signaling
RCTM RNO-877300 Interferon gamma signaling
RCTM RNO-8953897 Cellular responses to stimuli
RCTM RNO-913531 Interferon Signaling
RCTM RNO-936837 Ion transport by P-type ATPases
RCTM RNO-983712 Ion channel transport
WikiPathways WP1299 ErbB signaling pathway
WikiPathways WP140 Myometrial relaxation and contraction pathways
WikiPathways WP375 Wnt signaling pathway
KEGG rno04012 ErbB signaling pathway
KEGG rno04020 Calcium signaling pathway
KEGG rno04024 cAMP signaling pathway
KEGG rno04066 HIF-1 signaling pathway
KEGG rno04114 Oocyte meiosis
KEGG rno04148 Efferocytosis
KEGG rno04217 Necroptosis
KEGG rno04261 Adrenergic signaling in cardiomyocytes
KEGG rno04310 Wnt signaling pathway
KEGG rno04360 Axon guidance
KEGG rno04713 Circadian entrainment
KEGG rno04720 Long-term potentiation
KEGG rno04722 Neurotrophin signaling pathway
KEGG rno04725 Cholinergic synapse
KEGG rno04728 Dopaminergic synapse
KEGG rno04740 Olfactory transduction
KEGG rno04750 Inflammatory mediator regulation of TRP channels
KEGG rno04911 Insulin secretion
KEGG rno04912 GnRH signaling pathway
KEGG rno04916 Melanogenesis
KEGG rno04921 Oxytocin signaling pathway
KEGG rno04922 Glucagon signaling pathway
KEGG rno04925 Aldosterone synthesis and secretion
KEGG rno04934 Cushing syndrome
KEGG rno04971 Gastric acid secretion
KEGG rno05012 Parkinson disease
KEGG rno05022 Pathways of neurodegeneration - multiple diseases
KEGG rno05031 Amphetamine addiction
KEGG rno05152 Tuberculosis
KEGG rno05200 Pathways in cancer
KEGG rno05205 Proteoglycans in cancer
KEGG rno05214 Glioma
KEGG rno05415 Diabetic cardiomyopathy
KEGG rno05417 Lipid and atherosclerosis

Expression profile of Camk2a in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 4.538028
GSM2685202 MX2 tissue: Myocardium gender: female 4.8344316
GSM2685203 MX3 tissue: Myocardium gender: female 4.274234
GSM2685204 MX4 tissue: Myocardium gender: male 4.4434977
GSM2685205 DZ1 tissue: Myocardium gender: male 4.669832
GSM2685206 DZ2 tissue: Myocardium gender: male 4.9978456
GSM2685207 DZ3 tissue: Myocardium gender: female 4.547084
GSM2685208 DZ4 tissue: Myocardium gender: female 4.7168484
GSM2685209 JJ1 tissue: Myocardium gender: male 4.469436
GSM2685210 JJ2 tissue: Myocardium gender: female 4.124899
GSM2685211 JJ3 tissue: Myocardium gender: female 4.021868
GSM2685212 JJ4 tissue: Myocardium gender: male 4.4171686
GSM2685213 NG1 tissue: Myocardium gender: male 4.4283338
GSM2685214 NG2 tissue: Myocardium gender: female 4.0382943
GSM2685215 NG3 tissue: Myocardium gender: male 4.1764293
GSM2685216 NG4 tissue: Myocardium gender: female 4.405458
GSM2685217 YL1 tissue: Myocardium gender: male 4.4457107
GSM2685218 YL2 tissue: Myocardium gender: male 4.4263144
GSM2685219 YL3 tissue: Myocardium gender: female 4.949136
GSM2685220 YL4 tissue: Myocardium gender: female 4.586694
GSM2685221 QC1 tissue: Myocardium gender: male 4.327267
GSM2685222 QC2 tissue: Myocardium gender: male 4.3508515
GSM2685223 QC3 tissue: Myocardium gender: female 4.2632804
GSM2685224 QC4 tissue: Myocardium gender: female 3.7998686

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.873337894
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 7.087716351
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.901746835
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.517873656
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.551362482
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.37212226

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 10.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 5.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 7.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 12.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 26.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 3.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 9.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 17.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 11.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 12.07351
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 11.94417
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 11.92216
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 11.83678
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 12.04201
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 11.93138

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 29.948
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 38.892
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 42.267
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 18.658
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 30.511

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 9.148189584999999
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 8.940539676666667
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 8.788925959666665

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 108.0
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 74.55
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 63.9
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 61.9
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 46.45
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 24.950000000000003
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 24.9
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 71.75
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 47.65
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 54.55
GSM27494 CTL_a (control, 1st replicate) 50.05
GSM27495 CTL_b (control, 2nd replicate) 59.7
GSM27496 CTL_c (control, 3rd replicate) 53.349999999999994
GSM27497 CTL_d (control, 4th replicate) 55.8
GSM27498 CTL_e (control, 5th replicate) 74.39999999999999
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 31.2
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 66.3
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 48.3
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 61.0
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 62.2
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 21.65
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 25.700000000000003
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 64.4
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 39.25
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 73.4
GSM27509 ISCH_a (ischemia, 1st replicate) 68.95
GSM27510 ISCH_b (ischemia, 2nd replicate) 49.150000000000006
GSM27511 ISCH_c (ischemia, 3rd replicate) 58.95
GSM27512 ISCH_d (ischemia, 4th replicate) 68.35
GSM27513 ISCH_e (ischemia, 5th replicate) 59.3

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 1187.8999999999999
GSM30791 baseline control 02 male, 275-300g 506.15
GSM30792 baseline control 03 male, 275-300g 726.5
GSM30793 baseline control 04 male, 275-300g 1745.65
GSM30794 baseline control 05 male, 275-300g 1047.0
GSM30795 baseline control 06 male, 275-300g 949.9499999999999
GSM30796 baseline control 07 male, 275-300g 897.4
GSM30797 baseline control 08 male, 275-300g 1038.6
GSM30798 baseline control 09 male, 275-300g 1404.8500000000001
GSM30799 pain 01 1212.45
GSM30800 pain 02 530.15
GSM30801 pain 03 1076.0
GSM30802 pain 04 947.25
GSM30803 pain 05 666.7
GSM30804 FC 01 1457.55
GSM30805 FC 02 1512.8999999999999
GSM30806 FC 03 849.75
GSM30807 FC 04 1163.65
GSM30808 FC 05 1256.15
GSM30809 IFC 01 767.85
GSM30810 IFC 02 1447.0
GSM30811 IFC 03 1624.65
GSM30812 IFC 04 1044.95
GSM30813 IFC 05 858.1500000000001
GSM99800 isoflurane 01 male, 275-300g 842.2
GSM99801 isoflurane 02 male, 275-300g 1032.75
GSM99802 isoflurane 03 male, 275-300g 1087.95
GSM99803 isoflurane 04 male, 275-300g 841.8
GSM99804 isoflurane 05 male, 275-300g 1221.6499999999999

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 9.2277
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 9.389766666666667
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 8.978866666666667
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 8.693866666666667
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 9.677933333333334
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 8.2357
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 8.883066666666666
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 9.250766666666665
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 8.625866666666667

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 11.5933
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 11.7831
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 8.49528
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 9.07875
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 13.8123
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 13.6102
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 9.45414
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 9.46482
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 11.6411
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 11.7983
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 8.11159
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 8.75105
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 13.318
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 13.2264
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 8.86074
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 8.84217

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.436414
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.622414
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.757814
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.651622
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.402541
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.512582
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.742508
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.365995
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.619647
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.427612
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.524283
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.351033
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.538191
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.370828
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 5.708874
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.531867
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.642259
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.733877
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.734146
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 5.506767
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.436602
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.493474
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.678873
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.608733
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.41331
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.457087
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.541645
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.417082
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.442462
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.328563
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.285927
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.477819
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.326913
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.601197
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 5.642209
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.394258
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.413775
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.253985
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.541898
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 5.422087
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.610523
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.504499
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.369179
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.409355
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 5.570373

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 4267.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 5374.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 5714.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 5616.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 5571.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 4869.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 5381.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 5601.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 5226.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 6070.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 4511.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 5086.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 6318.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 5998.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 5025.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 4201.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4675.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4865.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4530.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 5197.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4752.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6517.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 5085.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4889.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 4733.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 4870.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 6639.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5830.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5996.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5845.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 6350.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 6235.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 6748.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6271.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5805.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5044.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 0.014123
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.091984
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 0.102027
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 0.079682

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.073
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 -0.0784
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.083
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.105
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.0186
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 -0.0421
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0393
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 -0.0215
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0597
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.00751
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.0085
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.0218

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 36.95
GSM5121 Isoflurane single exposure control-2 35.0
GSM5122 Isoflurane single exposure control-3 24.900000000000002
GSM5124 Isoflurane single exposure 1 hr-1 29.8
GSM5126 Isoflurane single exposure 1 hr-2 43.45
GSM5127 Isoflurane single exposure 2 hr-1 36.25
GSM5130 Isoflurane single exposure 2 hr-2 54.55
GSM5131 Isoflurane single exposure 2 hr-3 37.2

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.7957903319999997
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.9660505693333334
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.5546376973333333
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.7684880780000003
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.735992421
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.7900570289999997
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.957603519333334
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.842858570666666
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.7410587523333327
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.825744667666667
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.8756950736666664
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5814678366666666
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.8840105103333333
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.8568245856666667
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.240588520666667
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.9356081503333336
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.193171469666667
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.061013160333333
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.9111420970000004
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.783116122333334
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.756707615333333
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.887609086
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.7796646133333334
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.6258169280000003

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.879797
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.770498
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.819824
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.898392
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.845315
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.769428
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.906021
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.874404
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.837933
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.87169
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.912152
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.936262
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.975492
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.896668
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.002454
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.844357
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.781523
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.90274
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.839594
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.765467
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.800432
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.962906
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.842955
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.854564

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 498.2992
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 643.2922

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 134.52585771333332
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 37.63597351666667
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 43.77118435566667
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 85.85890291466667
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 56.274035185
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 106.2594796
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 11.346856203333333
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 64.08087014
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 85.510627882
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 77.55446325333334
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 16.149891844666666
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 125.18796106
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 97.48784063
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 107.60727610733333

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.7957903319999997
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 3.9660505693333334
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.5546376973333333
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 3.7684880780000003
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.735992421
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.7900570289999997
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.957603519333334
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 3.842858570666666
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.7410587523333327
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.825744667666667
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.8756950736666664
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 3.5814678366666666
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.8840105103333333
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 3.8568245856666667
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.240588520666667
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.9356081503333336
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.193171469666667
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.061013160333333
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.9111420970000004
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 3.783116122333334
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.756707615333333
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 3.887609086
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.7796646133333334
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 3.6258169280000003
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 134.52585771333332
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 37.63597351666667
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 43.77118435566667
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 85.85890291466667
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 56.274035185
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 106.2594796
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 11.346856203333333
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 64.08087014
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 85.510627882
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 77.55446325333334
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 16.149891844666666
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 125.18796106
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 97.48784063
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 107.60727610733333

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 27.55
GSM5084 Control 2 22.85
GSM5085 Control 3 51.400000000000006
GSM5086 Control 4 37.05
GSM5087 Control 5 34.9
GSM5090 Control 6 34.35
GSM5105 Control 7 25.7
GSM5106 Control 8 36.4
GSM5107 Control 9 34.699999999999996
GSM5108 Halothane 10 exposure-1 24.5
GSM5109 Halothane 10 exposures-2 26.349999999999998
GSM5110 Halothane 10 exposures-3 34.45
GSM5111 Halothane 5 exposures-1 25.8
GSM5112 Halothane 5 exposures-2 25.45
GSM5113 Halothane 5 exposures-3 36.35
GSM5114 Isoflurane 10 exposures-1 20.25
GSM5115 Isoflurane 10 exposures-2 44.550000000000004
GSM5116 Isoflurane 10 exposures-3 31.75
GSM5117 Isoflurane 5 exposures-1 37.75
GSM5118 Isoflurane 5 exposures-2 35.35
GSM5119 Isoflurane 5 exposures-3 34.6
GSM11379 Control 10 47.05
GSM11380 Control 11 46.75
GSM11381 Control 12 39.05

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 31.642800000000005
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 62.207966666666664